Stay informed
Sign up to receive more information and updates about EVKEEZA®.
Restez au courant
Inscrivez-vous pour recevoir de plus amples renseignements et des mises à jour concernant EVKEEZA.
Information for Canadian patients,
caregivers and healthcare professionals
Have you or your child been prescribed EVKEEZA®?
Please enter the DIN from your prescription. It can be found on the website card in your enrolment package.
Invalid DIN
Are you a Canadian healthcare professional?
Please enter the following information.
Invalid license number
This site is intended for Canadian audiences only.
© 2024 Regeneron Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical, Inc. All rights reserved. EVKEEZA is a registered trademark of Regeneron Pharmaceuticals, Inc. UltraCare is a registered trademark of Ultragenyx Pharmaceutical, Inc.
MRCP-UX858-00114 05/2024
You are now leaving the EVKEEZA website
Links to other websites are provided as a convenience to the viewer. Ultragenyx accepts no responsibility for the content of the linked sites.
This site uses cookies to provide you with a more responsive and personalized service. By clicking "Accept," you agree to the use of cookies on this site. Please read our Cookie Policy and Privacy Policy for more information on the use of cookies on this website.
Important Safety Information
Indications and clinical use:
EVKEEZA® (evinacumab for injection) is indicated as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH).
The effects of EVKEEZA on cardiovascular morbidity and mortality have not been determined.
Contraindications:
EVKEEZA is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient or component of the container.
Relevant warnings and precautions:
- Hypersensitivity and infusion reactions
- Fertility
- Teratogenic risk
Please consult the product monograph at https://evkeeza.ca/hcp/pdfs/Evkeeza_Final_PM.pdf for important information relating to adverse reactions, breastfeeding, drug interactions, and dosing.
The product monograph is also available by calling us at 1-833-388-5872.